Send feedback

CPSF3 p.Val637Ile

c.1909G>A · rs199631426 · VCV2367837

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.0828 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0571%, sas)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense0.0828likely benign
REVEL0.044moderately benign-leaning
SaProtLLR -7.94tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.4GERP 1.9, phastCons 1
Regional constrainto/e 0.83unconstrained · MANE · 20 kb · p 0.011 · regional, not allelic
Overall
CADD21.3PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0571% South Asian · 52/91,062 alleles
Filtering AF 0.0447% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0403%
Overall 0.0104% 167/1,612,734 alleles · ultra-rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.0947% 1,056
South Asiangrpmax 0.0571% 1,751
Remaining individualsnot grpmax-eligible 0.0176% 5,677
Middle Eastern 0.0165% 6,058
African / African-American 0.008% 12,502
European (non-Finnish) 0.00568% 17,595
East Asian 0.00223% 44,852
Admixed American 0.00167% 60,004

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CPSF3
Protein
p.Val637Ile
Coding
c.1909G>A
MANE Select
NM_016207
dbSNP
rs199631426
Type
single nucleotide variant
Location
chr2:9471395 (GRCh38)
Gene constraint
LOEUF 1.01 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 90.41 · 10 PDB
Full CPSF3 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cpsf3-p-val637ile (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown